News

Meta: In July of 2025, the U.S. Food and Drug Administration approved various anti-cancer treatments and therapeutic ...
The FDA is mandating new labeling for opioids to better inform patients and healthcare providers about the risks of addiction ...
The combination of potential cancer drugs may provide a breakthrough approach for treating Alzheimer's disease by reversing ...
At the urging of another person in the recovery community, Yates said his best friend stopped taking buprenorphine — a ...
Semaglutide is the active ingredient in the weight loss medication Wegovy and the diabetes drugs Ozempic and Rybelsus, which ...
US FDA grants fast track designation to Revalesio’s lead investigational therapy, RNS60 to treat acute ischemic stroke: Tacoma, Washington Saturday, August 2, 2025, 15:00 Hrs [I ...
Hepatitis C is a silent epidemic in the U.S., affecting up to 4 million people, according to the Centers for Disease Control ...
US FDA requires major changes to opioid pain medication labelling to emphasize risks: Maryland Saturday, August 2, 2025, 11:00 Hrs [IST] The US Food and Drug Administration (FDA) ...
Some of the most recognizable brand names that could be impacted by new tariffs include Ozempic and Wegovy, two injectable ...
Insightec, the Miami-based innovator in focused ultrasound to transform patient care, announced July 8 the U.S. Food and Drug ...
Two women, who attended the "Revolution Against Aging and Death Festival" in Las Vegas, received peptide injections, had to ...